ARE THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDELINES THAT PROMULGATE ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER JUSTIFIED BY THE AVAILABLE EVIDENCE?

✍ Scribed by Roger S. Kirby; John M. Fitzpatrick

• Book ID: 109054389
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 58 KB
• Volume: 102
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2008.08061.x